Vimarsana
Biggest News Aggregation in the World

Page 4 - Global Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Study Today - Breaking & Trending Today

Killings hit record high in 2021 as post-lockdown stress grew - UN - Vimarsana News

Killings hit record high in 2021 as post-lockdown stress grew - UN

The number of murders and other intentional killings surged to a record high across the world in 2021, driven in part by the stress and economic pressures of COVID-19 lockdowns, a U.N. report said... -December 08, 2023 at 08:06 am EST - MarketScreener

Killings hit record high in 2021 as post-lockdown stress grew - Vimarsana News

Killings hit record high in 2021 as post-lockdown stress grew

The number of murders and other intentional killings surged to a record high across the world in 2021, driven in part by the stress and economic pressures of COVID-19 lockdowns, a U.N. report said on Friday. Around 458,000 people were killed intentionally, higher than the 400,000 to 450,000 recorded every year since researchers started collating the data in 2000, the United Nations Office on Drugs and Crime (UNODC) Global Study on Homicide said. Escalations in gang or political violence in Ecuador, Myanmar and other countries played their part, the study said.

Source: yahoo.com
Killings hit record high in 2021 as post-lockdown stress grew - UN - Vimarsana News

Killings hit record high in 2021 as post-lockdown stress grew - UN

VIENNA : The number of murders and other intentional killings surged to a record high across the world in 2021, driven in part by the stress and economic pressures of COVID-19 lockdowns, a U.N. report said on Friday.Around 458,000 people were killed intentionally, higher than the 400,000 to 450,000 record

Will AI companions replace the prospectus? - Vimarsana News

Will AI companions replace the prospectus?

Companies are supporting universities to radically redefine how they offer course and application guidance, with AI companions on the scene.

First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591 - Vimarsana News

First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company's Phase III ProstACT GLOBAL study of its investigational prostate-specific membrane antigen (PSMA) targeting radio-antibody drug conjugate (rADC) therapy, TLX591 (177Lu-rosopatamab tetraxetan). TLX591 is a rADC composed of a high-specificity PSMA-targeting antibody, chelator linker, and cytotoxic lutetium (177Lu) payload. The PSMA-targeted monoclonal antibody (mAb) ap

Source: yahoo.com